Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent van der Noort

Showing results (11-20 of 108) with videos related to

Pageof 11
Sort By:
Journal for Immunotherapy of Cancer|February 6, 2025
Pembrolizumab hybrid dosing is non-inferior to flat dosing in advanced non-small cell lung cancer: a real-world, retrospective bicenter cohort studyMichiel M Smeenk, Vincent van der Noort, Jeroen M A Hendrikx, et al.
Lung Cancer (Amsterdam, Netherlands)|April 15, 2024
The optimal treatment for patients with stage I non-small cell lung cancer: minimally invasive lobectomy versus stereotactic ablative radiotherapy - a nationwide cohort studyJulianne Cynthia de Ruiter, Vincent van der Noort, Judi Nani Annet van Diessen, et al.
Lung Cancer (Amsterdam, Netherlands)|September 19, 2022
Immune cells in mesothelioma microenvironment simplistic marker of response to nivolumab plus ipilimumab?Maria J Disselhorst, Yoni Lubeck, Vincent van der Noort, et al.
ERJ Open Research|December 24, 2025
The effect of pirfenidone on disease progression in asbestosis patients: a real-world Dutch cohort studyIllaa Smesseim, Anne E Wind, Jelle R Miedema, et al.
Neuroendocrinology|November 1, 2014
Grading of neuroendocrine neoplasms: mitoses and Ki-67 are both essentialMarie-Louise F van Velthuysen, Emma J Groen, Vincent van der Noort, et al.
Head & Neck|February 3, 2017
Ex vivo humidifying capacity and patient acceptability of stoma cloths in laryngectomized individualsLiset Lansaat, Cindy van den Boer, Sara H Muller, et al.
British Journal of Cancer|January 8, 2026
Stage I non-small cell lung cancer: improving patient selection for minimally invasive lobectomy or stereotactic ablative radiotherapy based on clinical characteristicsJulianne Cynthia de Ruiter, Vincent van der Noort, Judi Nani Annet van Diessen, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|March 29, 2022
Minimally invasive lobectomy versus stereotactic ablative radiotherapy for stage I non-small cell lung cancerJulianne Cynthia de Ruiter, Judi Nani Annet van Diessen, Egbert Frederik Smit, et al.
Journal of Cancer Research and Clinical Oncology|June 23, 2020
PI3K pathway protein analyses in metastatic breast cancer patients receiving standard everolimus and exemestaneDinja T Kruger, Mark Opdam, Vincent van der Noort, et al.
International Journal of Cancer|September 7, 2019
IGF-1R pathway activation as putative biomarker for linsitinib therapy to revert tamoxifen resistance in ER-positive breast cancerDinja T Kruger, Xanthippi Alexi, Mark Opdam, et al.
Pageof 11

Showing results (11-20 of 108) with videos related to

Sort By:
Pageof 11
Journal for Immunotherapy of Cancer|February 6, 2025
Pembrolizumab hybrid dosing is non-inferior to flat dosing in advanced non-small cell lung cancer: a real-world, retrospective bicenter cohort studyMichiel M Smeenk, Vincent van der Noort, Jeroen M A Hendrikx, et al.
Lung Cancer (Amsterdam, Netherlands)|April 15, 2024
The optimal treatment for patients with stage I non-small cell lung cancer: minimally invasive lobectomy versus stereotactic ablative radiotherapy - a nationwide cohort studyJulianne Cynthia de Ruiter, Vincent van der Noort, Judi Nani Annet van Diessen, et al.
Lung Cancer (Amsterdam, Netherlands)|September 19, 2022
Immune cells in mesothelioma microenvironment simplistic marker of response to nivolumab plus ipilimumab?Maria J Disselhorst, Yoni Lubeck, Vincent van der Noort, et al.
ERJ Open Research|December 24, 2025
The effect of pirfenidone on disease progression in asbestosis patients: a real-world Dutch cohort studyIllaa Smesseim, Anne E Wind, Jelle R Miedema, et al.
Neuroendocrinology|November 1, 2014
Grading of neuroendocrine neoplasms: mitoses and Ki-67 are both essentialMarie-Louise F van Velthuysen, Emma J Groen, Vincent van der Noort, et al.
Head & Neck|February 3, 2017
Ex vivo humidifying capacity and patient acceptability of stoma cloths in laryngectomized individualsLiset Lansaat, Cindy van den Boer, Sara H Muller, et al.
British Journal of Cancer|January 8, 2026
Stage I non-small cell lung cancer: improving patient selection for minimally invasive lobectomy or stereotactic ablative radiotherapy based on clinical characteristicsJulianne Cynthia de Ruiter, Vincent van der Noort, Judi Nani Annet van Diessen, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|March 29, 2022
Minimally invasive lobectomy versus stereotactic ablative radiotherapy for stage I non-small cell lung cancerJulianne Cynthia de Ruiter, Judi Nani Annet van Diessen, Egbert Frederik Smit, et al.
Journal of Cancer Research and Clinical Oncology|June 23, 2020
PI3K pathway protein analyses in metastatic breast cancer patients receiving standard everolimus and exemestaneDinja T Kruger, Mark Opdam, Vincent van der Noort, et al.
International Journal of Cancer|September 7, 2019
IGF-1R pathway activation as putative biomarker for linsitinib therapy to revert tamoxifen resistance in ER-positive breast cancerDinja T Kruger, Xanthippi Alexi, Mark Opdam, et al.
Pageof 11